|
|
|
Volumn 13, Issue 2, 2000, Pages 88-94
|
|
A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZHYDRYL DERIVATIVE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CRESOL;
MANDELIC ACID DERIVATIVE;
OXYBUTYNIN;
PHENYLPROPANOLAMINE;
TOLTERODINE;
BUDGET;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
COST OF ILLNESS;
DRUG COST;
ECONOMICS;
HUMAN;
PATIENT COMPLIANCE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STATISTICS;
TREATMENT OUTCOME;
URINE INCONTINENCE;
BENZHYDRYL COMPOUNDS;
BUDGETS;
CHOLINERGIC ANTAGONISTS;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
CRESOLS;
DRUG COSTS;
HUMANS;
MANDELIC ACIDS;
PATIENT COMPLIANCE;
PHENYLPROPANOLAMINE;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
URINARY INCONTINENCE;
|
|
EID: 0034136746
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (24)
|
|
References (18)
|
